| Bioactivity | Tauro-α-muricholic acid (T-α-MCA) sodium is a FXR (Farnesoid X receptor) antagonist (IC50=28μM). Tauro-α-muricholic acid sodium is also a endogenous metabolite that can be found in cecal[1][2]. |
| Name | Tauro-α-muricholic acid sodium |
| CAS | 2260905-08-4 |
| Formula | C26H44NNaO7S |
| Molar Mass | 537.68 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chen W, et al. Farnesoid X receptor is inhibited after ileum transposition in diabetic rats: its hypoglycemic effect. Int J Med Sci. 2023 Apr 2;20(5):595-605. [2]. Ye X, et al. Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism. Eur J Pharmacol. 2021 Oct 5;908:174341. |
Tauro-α-muricholic acid sodium
CAS: 2260905-08-4 F: C26H44NNaO7S W: 537.68
Tauro-α-muricholic acid (T-α-MCA) sodium is a FXR (Farnesoid X receptor) antagonist (IC50=28μM). Tauro-α-muricholic
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.